AAAAAA

   
Results: 1-19 |
Results: 19
Aldosterone and myocardial infarction - Are aldosterone antagonists neededto prevent remodelling or does ACE inhibition suffice ?
Authors: Remme, WJ
Citation: Wj. Remme, Aldosterone and myocardial infarction - Are aldosterone antagonists neededto prevent remodelling or does ACE inhibition suffice ?, CARDIO DRUG, 15(4), 2001, pp. 297-298
Dopaminergic agents in heart failure: Rebirth of an old concept
Authors: Remme, WJ
Citation: Wj. Remme, Dopaminergic agents in heart failure: Rebirth of an old concept, CARDIO DRUG, 15(2), 2001, pp. 107-109
The Carvedilol and ACE-inhibitor Remodelling Mild Heart Failure EvaluationTrial (CARMEN) - Rationale and design
Authors: Remme, WJ
Citation: Wj. Remme, The Carvedilol and ACE-inhibitor Remodelling Mild Heart Failure EvaluationTrial (CARMEN) - Rationale and design, CARDIO DRUG, 15(1), 2001, pp. 69-77
Guidelines for the diagnosis and treatment of chronic heart failure (vol 22, pg 1527, 2001)
Authors: Remme, WJ Swedberg, K
Citation: Wj. Remme et K. Swedberg, Guidelines for the diagnosis and treatment of chronic heart failure (vol 22, pg 1527, 2001), EUR HEART J, 22(23), 2001, pp. 2217-2218
Guidelines for the diagnosis and treatment of chronic heart failure
Authors: Remme, WJ Swedberg, K
Citation: Wj. Remme et K. Swedberg, Guidelines for the diagnosis and treatment of chronic heart failure, EUR HEART J, 22(17), 2001, pp. 1527-1560
Reduced costs with bisoprolol treatment for heart failure - An economic analysis of the second Cardiac Insufficiency Bisoprolol Study (CIBIS-II)
Authors: Bacquet, P Levy, E McGuire, A McMurray, J Merot, JL Paschen, B Remme, WJ Szucs, TD Klein, W Brunhuber, W Hofmann, R Kuhn, P Nesser, HJ Slany, J Weihs, W Wiedermann, C Wimmer, H van Mieghem, W Boland, J Chaudron, JM Jordaens, L Melchior, JP Aschermann, M Bruthansl, J Hradec, M Kolbel, F Semrad, B Haghfelt, T Hansen, JF Goetzsche, CO Hildebrandt, P Kassis, E Rasmussen, V Rokkedal, J Thomassen, A Groundstroem, K Uusimaa, P Le Heuzey, JY Aumont, MC Aupetit, JF Baille, N Baudouy, P Belin, A Bonneau, A Bonneric, G Bousser, JP Citron, B Dary, P Decoulx, E De Groote, P Denolle, T Dievart, F Duriez, P Eicher, JC Enjuto, G Ferriere, M Fournier, E Garandeau, M Gauthier, J Genest, M Gerbe, A Godenir, JP Guillot, B Guillot, JP Guillot, P Heno, P d'Ivernois, C Jean, M Kacet, S Kalle, R Komajda, M Lacroix, A Lallemand, R Lardoux, H Marquet, M Martin, M Martin, O Mery, D Mossaz, R Mothes, P Olive, T Ostorero, M Paganelli, F Page, E Pauly-Laubry, C Puel, J Rousseau, JF Roux, JJ Schenowitz, A Sourdais, K Tremel, F Verdun, A Witchiz, S Wolf, JE Hombach, V Assmann, I Beyer, T Bischoff, KO Darius, H Ertl, G Fleck, E Forster, K Freytag, F Gleichmann, U Haasis, R Henssge, R Hey, D Hesse, P Hofs, T Keck, M Klein, H Kromer, ET Kruls-Munch, J Luderitz, B Maisch, B Mitrovic, V Neubauer, S Osterziel, KJ Simon, H Spitzer, SG Stohring, R Taubert, G Teichmann, W Theisen, K Wende, W Wieser, H Zotz, R Bridges, A Adgey, J Ambepitiya, G Boon, N Boyle, RM Cowley, AJ Cripps, T Davies, MK Dunn, F Findlay, J Forsey, P Fyfe, T Gould, B Greenwood, TW Hubner, P Khan, S Lewis, P Mackay, A Maltz, M McArthur, J McLeod, A McLeod, D Metcalfe, M Millar-Craig, M Mills, P Nelson, JK Nicholls, D Oakley, GD Patterson, DLH Pohl, JEF Ray, S Silke, B Wilkinson, PR Preda, I Csanady, M Cserhalmi, L Edes, I Gesztesi, T Karpati, P Simon, K Tarjan, J Fogari, R Tramarin, R Galie, N Giani, P Milanese, U Scalvini, S Scrutinio, D Sechi, LA Tettamanti, F De Vito, F Crean, P McCann, H Mulcahy, D Sugrue, D van Hoogenhuyze, DCA van der Burgh, PH Ciampricotti, R van Dantzig, JM DenHartog, FR Henneman, JA van Kesteren, HAM Kragten, JA Liem, KL Limburg, A van der Linde, MR Linssen, GCM Pasteuning, H Penn, HJAM Van Rossum, P Schaafsma, HJ Schelling, A Sloos, R Wesdorp, JCL Korewicki, J Achremczyk, P Czestockowska, E Dowgird, M Dyduszynski, A Gorski, J Ilmurzynska, K Janicki, K Kornacewicz-Jach, Z Kraska, T Krzeminska-Pakula, M Kuch, J Nartowicz, E Petelenz, T Piwowarska, W Rawczynska-Englert, I Ruzyllo, W Swiatecka, G Tendera, M Wierzchowiecki, M Wodniecki, J Wojciechowoski, D Wrabec, K Wysocki, H Gomes, RS Ceia, MF Lousada, N Campos, JMM Providencia, LA de Moura, ALZC Marejev, VJ Aronov, DM Arutjunov, GP Bart, BJ Basechikin, SS Belenkov, JN Beloussov, JB Bokeria, OA Charchogljan, RA Doschytsin, V Fedorova, TA Glezer, MG Gorbachenkov, A",Gorshkov,"Gospodarenko, AL Ivashkin, VT Ivleva, AJ Kyrichenko, AA Lavrov, AA Lazebnik, LB Marynov, A Mazaev, VP Polejev, NR",Shpektor,"Sidorenko, BA Sobolev, KE Starodoubtsev, AK Storozhakhov, GI Syrkin, AL Zodionchenko, VS Zvereva, TV Murin, J Kaliska, G Rybar, R Valle, V Artaza, M Conthe, P Cruz, JM Garcia-Moll, M Lopez-Sendon, JL Martinez, A Monzon, F Ribas, M Roig, E Roldan, I Hoglund, C Ekdahl, S Hjelmaeus, L Lindberg, K Lofdahl, P Ulvenstam, G Warselius, L Follath, F Anghern, W Dubach, P Erne, P Gallino, A Moccetti, T Jmouro, AV Dargie, HJ Erdmann, E Follath, F Hoglund, C Lechat, P Sendon, JLL Mareyev, V Remme, WJ Sadowski, Z Seabra-Gomes, RJ Zannad, F Wehrlen-Grandjean, M Funck-Brentano, C Hansen, S Hohnloser, S Vanoli, E Jaillon, P De Baker, G Dahlstrom, U Hill, C Leizorovicz, A Burgnard, F Rolland, C Wiemann, H Verkenne, P Arab, T Cussac, N Dussous, V Haise, S Funck-Brentano, C
Citation: P. Bacquet et al., Reduced costs with bisoprolol treatment for heart failure - An economic analysis of the second Cardiac Insufficiency Bisoprolol Study (CIBIS-II), EUR HEART J, 22(12), 2001, pp. 1021-1031
Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries
Authors: Kotseva, K Wood, D De Backer, G De Bacquer, D Pyorala, K Keil, U Sans, S Ambrosio, GB Amouyel, P Cokkinos, D Deckers, JW Erhardt, L Graham, I Gutzwiller, F Keber, I Keil, U Lehto, S Ostor, E Pajak, A Sans, S Simon, J Turk, J Wood, D Wood, DA Schofield, B Bowker, T Ingham, J McLennan, N Kotseva, K Gollapalli, M Valay, R De Backer, G De Bacquer, D James, D Mackness, M Simon, J Linhartova, K Hafman, P Mayer, O Rosolova, H Bocek, P Hrncarek, M Lupinek, P Marek, T Plaskova, M Skodova, Z Cifkova, R Lehto, S Lehto, R Kemppainen, A Koukkunen, H Luukkonen, J Puhakka, M Karkkainen, K Savolainen, K Amouyel, P Montaye, M Lemaire, B Danet, S Domanievicz, R Lenoir, M Beauchant, S Dusart, A Bonte, F Fievet, N Poissonnier, L Ledoux, P Marecaux, N Steclebout, C Keil, U Liese, A Broxtermann, U Heimbach, M Heidrich, J Kalic, M Breithardt, G Enbergs, A Kerber, S Scheld, H Roeder, N Kleine-Katthofer, P Assmann, G Ostor, E Borbas, S Podmaniczky, M Ruzsanyi, T Janosi, A Belatiny-Kenez, A Bradak, A Adam, Z Barczy, G Birtalan, K Gallai, I Ambrosio, GB Leprotti, C Zardini, P Rossi, L Gallo, A Tavella, D Stritoni, P Pedrocco, A Perissinotto, F Vanuzzo, D Pilotto, L Deckers, JW Post, F Jansen, C Veerhoek, M Boer, A Stockx, E van de Berg, R Remme, WJ van Vliet, R Vos, J van der Knaap, M Turk, J Keber, I Marn, K Salapura, V Skof, E Span, E Sans, S Paluzie, G Perez, I Puig, T Varas, C Balana, L Lopez, FN Sanz, G Ferrer, C de Luna, AB Caralps, JM Dominguez, M Monras, P Rey, M
Citation: K. Kotseva et al., Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries, LANCET, 357(9261), 2001, pp. 995-1001
Heart failure management: why evidence does not influence clinical practice
Authors: Remme, WJ
Citation: Wj. Remme, Heart failure management: why evidence does not influence clinical practice, EUR H J SUP, 2(I), 2000, pp. L15-L21
Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure
Authors: Nieminen, MS Akkila, J Hasenfuss, G Kleber, FX Lehtonen, LA Mitrovic, V Nyquist, O Remme, WJ
Citation: Ms. Nieminen et al., Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure, J AM COL C, 36(6), 2000, pp. 1903-1912
Overview of the relationship between ischemia and congestive heart failure
Authors: Remme, WJ
Citation: Wj. Remme, Overview of the relationship between ischemia and congestive heart failure, CLIN CARD, 23(7), 2000, pp. IV4-IV8
Dr. Stanley H. Taylor - In memoriam
Authors: Remme, WJ
Citation: Wj. Remme, Dr. Stanley H. Taylor - In memoriam, CARDIO DRUG, 13(4), 1999, pp. 285-286
Drug-induced heart failure
Authors: Feenstra, J Grobbee, DE Remme, WJ Stricker, BHC
Citation: J. Feenstra et al., Drug-induced heart failure, J AM COL C, 33(5), 1999, pp. 1152-1162
Modulation of the renin-angiotensin-aldosterone system - pivotal in heart failure treatment
Authors: Remme, WJ
Citation: Wj. Remme, Modulation of the renin-angiotensin-aldosterone system - pivotal in heart failure treatment, Z KARDIOL, 88, 1999, pp. 12-17
Differential anti-ischaemic effects of muscarinic receptor blockade in patients with obstructive coronary artery disease - impaired vs normal left ventricular function
Authors: van den Heuvel, AFM van Veldhuisen, DJ Bartels, GL van der Ent, M Remme, WJ
Citation: Afm. Van Den Heuvel et al., Differential anti-ischaemic effects of muscarinic receptor blockade in patients with obstructive coronary artery disease - impaired vs normal left ventricular function, EUR HEART J, 20(23), 1999, pp. 1717-1723
Treatment of congestive heart failure - Has the time come for decreased complexity?
Authors: Ryden, L Remme, WJ
Citation: L. Ryden et Wj. Remme, Treatment of congestive heart failure - Has the time come for decreased complexity?, EUR HEART J, 20(12), 1999, pp. 867-871
Sustained benefit at 10-14 years follow-up after thrombolytic therapy in myocardial infarction
Authors: Maas, ACP van Domburg, RT Deckers, JW Vermeer, F Remme, WJ Kamp, O Cats, VM Simoons, ML
Citation: Acp. Maas et al., Sustained benefit at 10-14 years follow-up after thrombolytic therapy in myocardial infarction, EUR HEART J, 20(11), 1999, pp. 819-826
Study on propionyl-L-carnitine in chronic heart failure
Authors: Anand, IS Francis, G Maseri, A Milazzotto, F Pepine, CJ Yusuf, S Beaufils, P Ferrari, R Poole-Wilson, PA Remme, WJ Schlepper, M Tavazzi, L Visioli, O Zarco, P Lubsen, J Jacono, A Kjekshus, J Bruzzi, P Marubini, E Victor, N De Giuli, F Opasich, C Pasini, E Klein, W Bounhoure, JP Cohen, SA Page, E Zannad, F Grosser, K Rettig-Sturmer, G Ciampricotti, R de Boo, J den Hartog, F Huige, MC Kragten, H Penn, H Visser, F Bernardi, D Caponnetto, S Cardoni, C Chiariello, M Cobelli, F Cucchini, F De Ambroggi, L Del Citerna, F De Ponti, CL Giannuzzi, P Giordano, A Giusti, C Lotto, A Maseri, A Magnani, B Rengo, F Rengo, F Scrutinio, D Toso, M Vergassola, R Zanuttini, D Llosa, C Montero, JM de la Calzada, CS Soler, S Zarco, P Adamec, R Martina, B Noble, M Sutton, G Yellon, D
Citation: Is. Anand et al., Study on propionyl-L-carnitine in chronic heart failure, EUR HEART J, 20(1), 1999, pp. 70-76
The effect of spironolactone on morbidity and mortality in patients with severe heart failure
Authors: Pitt, B Zannad, F Remme, WJ Cody, R Castaigne, A Perez, A Palensky, J Wittes, J
Citation: B. Pitt et al., The effect of spironolactone on morbidity and mortality in patients with severe heart failure, N ENG J MED, 341(10), 1999, pp. 709-717
Acute anti-ischemic effects ef perindoprilat in men with coronary artery disease and their relation with left ventricular function
Authors: Bartels, GL van den Heuvel, AFM van Veldhuisen, DJ van der Ent, M Remme, WJ
Citation: Gl. Bartels et al., Acute anti-ischemic effects ef perindoprilat in men with coronary artery disease and their relation with left ventricular function, AM J CARD, 83(3), 1999, pp. 332-336
Risultati: 1-19 |